Jasper Therapeutics, Inc. - Equity Warrant

SecurityJSPRW / Jasper Therapeutics, Inc. - Equity Warrant
InstitutionWalleye Capital LLC
Latest Disclosed Ownership200,000 shares
Latest Disclosed Value $ 4,380
Walleye Capital LLC ownership in JSPRW / Jasper Therapeutics, Inc. - Equity Warrant

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 200,000 shares of Jasper Therapeutics, Inc. - Equity Warrant (US:JSPRW) valued at $4,380 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 200,000 shares of Jasper Therapeutics, Inc. - Equity Warrant. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 JASPER THERAPEUTICS *W EXP 09/24/202 471871111 200,000 0 0.00 4 -50.00 0.0000
2026-05-08 2026-03-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 200,000 0 4 0.0000
2026-02-13 2025-12-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 200,000 -360,061 -64.29 8 -81.82 0.0000
2025-11-14 2025-09-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 560,061 0 0.00 45 -36.23 0.0002
2025-08-13 2025-06-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 560,061 0 0.00 70 -13.75 0.0003
2025-05-14 2025-03-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 560,061 -13,579 -2.37 80 -33.33 0.0004
2025-02-13 2024-12-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 573,640 -22,374 -3.75 120 0.84 0.0003
2024-11-14 2024-09-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 596,014 0 0.00 119 0.00 0.0002
2024-08-14 2024-06-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 596,014 0 0.00 119 10.19 0.0002
2024-05-15 2024-03-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 596,014 -99,000 -14.24 108 96.36 0.0002
2024-02-14 2023-12-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 695,014 -5,422 -0.77 56 57.14 0.0001
2023-11-21 2023-09-30 13F/A-1 JASPER THERAPEUTICS *W EXP 09/24/202 471871111 700,436 -301 -0.04 35 -64.29 0.0001
2023-11-14 2023-09-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 700,436 -301 35 0.0001
2023-08-14 2023-06-30 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 700,737 45,903 7.01 98 -24.62 0.0004
2023-05-15 2023-03-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 654,834 629,775 2,513.17 131 0.0020
2023-02-14 2022-12-31 13F JASPER THERAPEUTICS *W EXP 09/24/202 471871111 25,059 0 0.00 1 -100.00 0.0000
2022-11-14 2022-09-30 13F JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 0 0.00 2 0.00 0.0000
2022-08-19 2022-06-30 13F/A-1 JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 0 0.00 2 -71.43 0.0001
2022-08-08 2022-06-30 13F JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 0 2 0.0001
2022-05-27 2022-03-31 13F/A-01 JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 0 0.00 7 -81.08 0.0002
2022-05-16 2022-03-31 13F JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 0 7 0.0001
2022-05-27 2021-12-31 13F/A-01 JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 -55,625 -68.94 37 -68.91 0.0011
2022-03-03 2021-12-31 13F JASPER THERAPEUTICS *W EXP 12/01/202 471871111 25,059 -55,625 37 0.0009
2021-11-15 2021-09-30 13F JASPER THERAPEUTICS *W EXP 12/01/202 471871111 80,684 80,684 119 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.